Search
for
Sort by
Research 91–120 of 1000+
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Surgical Treatment of Vitiligo
- Characterization of DNA Methylation and Screening of Epigenetic Markers in Polycystic Ovary Syndrome
- Changes in the PCOS phenotype with age
- Alternative androgen pathways
- Alopecia Universalis Associated with Hyperthyroidism Treated with Azathioprine and Hydroxychloroquine: A Case Report
- Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation
- Hypothesis: platelet-rich plasma as an adjunct therapy for eczema targeting inflammation, skin barrier repair, and chronic recurrence
- Hormone Blocking Anticancer Drugs
- Cerebral vasculitis as a severe complication of acute infectious meningoencephalitis—a case series of five different pathogens
- PŁYNY- NIE ZA DUŻO, NIE ZA MAŁO, LECZ W SAM RAZ
- Efficacy of Platelet-Rich Plasma Therapy in Oral Lichen Planus: A Systematic Review
- Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
- Polycystic Ovarian Morphology is Associated with Hyperandrogenemia and Insulin Resistance in Women with Polycystic Ovary Syndrome (PCOS)
- Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
- Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- The vitamin D receptor functions as a transcription regulator in the absence of 1,25-dihydroxyvitamin D3
- The impact of VDR expression and regulation in vivo
- Evaluation of Serum Levels of Nesfatin-1 and Insulin resistance in Patients with Acne Vulgaris
- Neuroactive Steroids and Ethanol Exposure: Relevance to Ethanol Sensitivity and Alcohol Use Disorders Risk
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Acanthosis nigricans, insulin resistance and cutaneous virilism
- Anabolic-androgenic steroids and cardiovascular risk